In addition, the overexpression of FOXM1 in MCF7 or Hela cells with relatively low endogenous levels of FOXM1 resulted in heightened sensitivity towards M1-20 (Supplemental Fig. 5B, C), supporting that M1-20’s anti-cancer efficacy correlated with the FOXM1 levels in cancer cells. Here, FOXM1 is linked to cancer.